| Viji Murugavel, MD | |
|
483 W Seed Farm Rd, Sacaton, AZ 85147-0038 | |
| (602) 528-1200 | |
| (602) 528-1255 |
| Full Name | Viji Murugavel |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Location | 483 W Seed Farm Rd, Sacaton, Arizona |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215918008 | NPI | - | NPPES |
| 458134002 | Other | AZ | APIPA |
| 5709935 | Other | AR | MEDICAL |
| AZ0758340 | Other | AZ | BCBS |
| 458134 | Medicaid | AZ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 26948 (Arizona) | Primary |
| Entity Name | Gila River Health Care Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376538231 PECOS PAC ID: 0648174185 Enrollment ID: O20031125000648 |
News Archive
Scientists at Schepens Eye Research Institute have found that when the eye is missing a diffusible form of vascular endothelial growth factor (VEGF), i.e. one that when secreted can reach other cells at a distance, the retina shows defects similar to "dry" macular degeneration, also called geographic atrophy (GA).
Treadmill desks can help overweight or obese office workers get out of their chairs and get moving, but a 12-week study by an Oregon State University researcher found that the increase in physical activity was small and did not help workers meet public health guidelines for daily exercise.
New research presented this week at ACR Convergence, the American College of Rheumatology's annual meeting, shows that people with difficult-to-treat rheumatoid arthritis who do not have success with one Janus kinase inhibitor (JAK inhibitor) can achieve success either cycling to other JAKi medications or switching to a biologic drug.
Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today that the investigational anti-Xa intravenous anticoagulant otamixaban reduced by 27 to 42 percent the odds of the composite primary endpoint of death, myocardial infarction, urgent revascularization or rescue GPIIb/IIIa use in 4 out of the 5 otamixaban tested doses, versus standard UFH/eptifibatide combination in [non-ST] ACS patients suitable for invasive strategy.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Viji Murugavel, MD Po Box 38, Sacaton, AZ 85147-0001 Ph: (602) 528-1200 | Viji Murugavel, MD 483 W Seed Farm Rd, Sacaton, AZ 85147-0038 Ph: (602) 528-1200 |
News Archive
Scientists at Schepens Eye Research Institute have found that when the eye is missing a diffusible form of vascular endothelial growth factor (VEGF), i.e. one that when secreted can reach other cells at a distance, the retina shows defects similar to "dry" macular degeneration, also called geographic atrophy (GA).
Treadmill desks can help overweight or obese office workers get out of their chairs and get moving, but a 12-week study by an Oregon State University researcher found that the increase in physical activity was small and did not help workers meet public health guidelines for daily exercise.
New research presented this week at ACR Convergence, the American College of Rheumatology's annual meeting, shows that people with difficult-to-treat rheumatoid arthritis who do not have success with one Janus kinase inhibitor (JAK inhibitor) can achieve success either cycling to other JAKi medications or switching to a biologic drug.
Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today that the investigational anti-Xa intravenous anticoagulant otamixaban reduced by 27 to 42 percent the odds of the composite primary endpoint of death, myocardial infarction, urgent revascularization or rescue GPIIb/IIIa use in 4 out of the 5 otamixaban tested doses, versus standard UFH/eptifibatide combination in [non-ST] ACS patients suitable for invasive strategy.
› Verified 2 days ago
Mrs. Ashley Marie Castillo, Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 483 W Seed Farm Rd, Sacaton, AZ 85147 Phone: 602-528-1200 Fax: 602-528-1483 | |
Dr. Adelaide P Bahr, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 483 W. Seed Farm Rd., Sacaton, AZ 85247 Phone: 602-528-1340 Fax: 602-528-1296 | |
Edwin Mgbam, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 483 W. Seed Farm Rd., Sacaton, AZ 85147 Phone: 602-528-1200 Fax: 602-528-1255 | |
Swathi Ponnathota, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 483 W Seed Farm Rd, Sacaton, AZ 85147 Phone: 602-528-1200 Fax: 602-528-1255 | |
Gilbert Harrison, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 483 W. Seed Farm Rd., Sacaton, AZ 85147 Phone: 602-528-1200 Fax: 602-528-1255 | |
Dr. Vincent Anthony Berkley, D.O. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 198 S. Skill Center Road, Sacaton, AZ 85147 Phone: 520-562-4208 Fax: 602-263-1619 |